Why the study?
Are adverse clinical and vessel characteristics associated with the risk of cardiac death or target-vessel myocardial infarction in patients undergoing drug-eluting stent implantation?
Are adverse clinical and vessel characteristics associated with the risk of cardiac death or target-vessel myocardial infarction in patients undergoing drug-eluting stent implantation?
Answers are grounded in this paper and cite their sources.
Integrative assessment of adverse clinical and vessel characteristics can optimize post-PCI risk stratification for hard clinical outcomes.
for trend <0.01). Conclusions In patients undergoing drug-eluting stent implantation, adverse clinical and vessel characteristics were associated with the risk of cardiac death or target-vessel myocardial infarction. Because these characteristics showed independent and additive prognostic value, their integrative assessment can optimize post-PCI risk stratification. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT04684043. www.crd.york.ac.uk/prospero/. Unique Identifier: CRD42021234748.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: